Related Experiment Videos
The clinical significance of type 1 fiber predominance
T Kyriakides1, J M Silberstein, S Jongpiputvanich
1Department of Neuropathology, Royal Perth Hospital, Western Australia.
Insights
Type 1 fiber predominance (T1FP) in children with hypotonia often indicates a neurological disorder. However, 40% of cases may represent a distinct T1FP entity, with most improving over time.
Area of Science:
- Neurology
- Pediatrics
- Muscle Histopathology
Background:
- Type 1 fiber predominance (T1FP) is a common finding in pediatric hypotonia muscle biopsies.
- The clinical significance and prognosis of T1FP remain unclear.
- T1FP can be associated with various neurological conditions or be idiopathic.
Purpose of the Study:
- To investigate the clinical significance of T1FP in children.
- To determine the long-term outcomes for children diagnosed with T1FP.
- To identify if T1FP represents a distinct clinical entity.
Main Methods:
- Longitudinal follow-up of 23 children diagnosed with T1FP.
- Clinical assessment for the development of neurological disorders.
- Analysis of muscle biopsy findings, specifically T1FP.
Main Results:
- A specific neurological disorder was identified in 60% of the children.
- 40% of children had no apparent neurological cause, suggesting a distinct T1FP entity.
- Most children with the distinct T1FP entity showed improvement, though some had residual motor deficits.
Conclusions:
- T1FP in pediatric hypotonia warrants careful evaluation for underlying neurological disorders.
- A subset of children with T1FP may represent a distinct clinical entity with a generally favorable prognosis.
- Understanding these outcomes is crucial for accurate patient and family counseling.
Abstract:
In the course of investigating children with hypotonia, muscle biopsy of the vastus lateralis frequently demonstrates greater than 55% predominance of the aerobic type 1 fibers of "type 1 fiber predominance" (T1FP). The clinical significance of T1FP is not well known. T1FP can be associated with a variety of neurological disorders but a significant proportion has no apparent cause. We followed up 23 children with T1FP to establish whether a neurological disorder subsequently became apparent or whether a distinct clinical entity of T1FP could be identified. Sixty percent of the children were found to have a specific neurological disorder, while 40% did not and may represent a distinct clinical entity. The majority of children with the clinical entity of T1FP improved although some were left with mild motor disability. Such information is important for counseling when patients with T1FP are first assessed.